Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Chemical Research in Toxicology|March 19, 2002
Reaction of malondialdehyde-DNA adducts with hydrazines-development of a facile assay for quantification of malondialdehyde equivalents in DNAMichael Otteneder, John P Plastaras, Lawrence J Marnett
Cancer Journal (Sudbury, Mass.)|November 22, 2014
Gastrointestinal cancer: nonliver proton therapy for gastrointestinal cancersJohn P Plastaras, Francesco Dionisi, Jennifer Y Wo
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 29, 2013
Radiation oncology: a primer for medical studentsAbigail T Berman, John P Plastaras, Neha Vapiwala
Annals of Palliative Medicine|July 23, 2024
Palliating hematologic oncologic emergencies with radiation in the age of targeted systemic therapies: three illustrative casesMonica Chelius, Meng Xu-Welliver, John P Plastaras
Seminars in Oncology|December 16, 2014
Special cases for proton beam radiotherapy: re-irradiation, lymphoma, and breast cancerJohn P Plastaras, Abigail T Berman, Gary M Freedman
Clinical Breast Cancer|November 10, 2005
Paget's disease of the nipple as local recurrence after breast-conservation treatment for early-stage breast cancerJohn P Plastaras, Eleanor E Harris, Lawrence J Solin
PET Clinics|May 10, 2016
The Use of PET in Radiation Therapy for LymphomaJohn P Plastaras, Geoffrey Geiger, Rodolfo Perini, et al.
Biochemistry|April 10, 2002
Effects of DNA structure on oxopropenylation by the endogenous mutagens malondialdehyde and base propenalJohn P Plastaras, Peter C Dedon, Lawrence J Marnett
Clinical Colorectal Cancer|October 14, 2009
Improved patient and regimen selection in locally advanced rectal cancer: who, how, and what next?Jared Weiss, Drew Moghanaki, John P Plastaras, et al.
Oncology (Williston Park, N.Y.)|December 22, 2022
The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory DiseaseGavin Jones, John P Plastaras, Andrea K Ng, et al.
Pageof 13